Signify Health, Inc. (56) | Bonus & Incentive Agreements (21)
Recent Contracts
-
Form of Signify Health, Inc. Amended and Restated Notice of Substitute of Non-Statutory Stock Option Grant (2019 Plan Performance-Based)
(Filed With SEC on March 3, 2022)
-
Form of Restricted Stock Unit Award Agreement Under Signify Health, Inc. 2021 Long-Term Incentive Plan
(Filed With SEC on May 12, 2021)
-
Form of Non-Qualified Stock Option Award Agreement Under Signify Health, Inc. 2021 Long-Term Incentive Plan
(Filed With SEC on May 12, 2021)
-
Form of Signify Health, Inc. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (time- and performance-vesting)
(Filed With SEC on March 25, 2021)
-
Form of Signify Health, Inc. Non-Qualified Stock Option Award Agreement under the 2021 Long-Term Incentive Plan (IPO Grants)
(Filed With SEC on March 25, 2021)
-
Form of Signify Health, Inc. Non-Employee Director Restricted Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan
(Filed With SEC on March 25, 2021)
-
Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Tad Kendall, dated February 16, 2021
(Filed With SEC on March 25, 2021)
-
Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Steven Senneff, dated February 16, 2021
(Filed With SEC on March 25, 2021)
-
Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester (time-and performance-vesting), dated February 16, 2021
(Filed With SEC on March 25, 2021)
-
Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester (time-vesting), dated February 16, 2021
(Filed With SEC on March 25, 2021)
-
Form of Signify Health, Inc. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (time-vesting)
(Filed With SEC on March 25, 2021)
-
Form of Signify Health, Inc. Long-Term Incentive Plan
(Filed With SEC on February 2, 2021)
-
New Remedy Corp. Amended and Restated 2019 Equity Incentive Plan
(Filed With SEC on January 19, 2021)
-
Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester, dated February 14, 2020
(Filed With SEC on January 19, 2021)
-
Form of Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and the Grantee
(Filed With SEC on January 19, 2021)
-
Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Tad Kendall dated February 14, 2020
(Filed With SEC on January 19, 2021)
-
Form of Class B Incentive Unit Award and Contribution Agreement between Chloe Ox Holdings, LLC, Chloe Ox Aggregator, LLC and the Grantee
(Filed With SEC on January 19, 2021)
-
Form of Class B Incentive Unit Award and Contribution Agreement between Chloe Ox Holdings, LLC, Chloe Ox Aggregator, LLC and the Grantee
(Filed With SEC on January 19, 2021)
-
Form of Remedy Partners, Inc. Notice of Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan
(Filed With SEC on January 19, 2021)
-
Form of New Remedy Corp. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan
(Filed With SEC on January 19, 2021)
-
Remedy Partners, Inc. 2019 Equity Incentive Plan
(Filed With SEC on January 19, 2021)